Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Use this NBIX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NBIX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NBIX SEC filings page. Lician reads the product cache first so this HTML stays unique to Neurocrine Biosciences Inc even when a live quote feed is slow.
Latest cached year on this hub. Full NBIX income, balance, and cash tables.